Safety and efficacy of G-CSF mobilization and collection of autologous peripheral blood stem cells in children with cerebral palsy

Transfusion and Apheresis Science

Volumn 49, Issue 3, 2013, Pages 516-521

  Moon, Jin Hwa ^a   Kim, Mi Jung ^a   Song, Soon Young ^a   Lee, Young Jun ^a   Choi, Yun Young ^a   Kim, Seung Hyun ^a   Lee, Young Ho ^a  

^a Hanyang University Medical Center   (South Korea)

Author keywords

Apheresis; Cerebral palsy; G CSF; Peripheral blood stem cell

Indexed keywords

ANTIPYRETIC AGENT; LEUCOSTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CENTRAL VENOUS CATHETER; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRRITABILITY; LUNG EMBOLISM; MALE; NEUROLOGIC DISEASE; PNEUMOTHORAX; PRESCHOOL CHILD; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; STEM CELL MOBILIZATION; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT OUTCOME;

APHERESIS; CEREBRAL PALSY; G-CSF; PERIPHERAL BLOOD STEM CELL;

BLOOD COMPONENT REMOVAL; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; TRANSPLANTATION, AUTOLOGOUS;

EID: 84888430695     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.08.003     Document Type: Article

References (36)

1. Swaiman K.F., Wu Y. Cerebral palsy. Pediatric neurology: principles & practice, vol. 1 2006, 491-504. Mosby, Philadelphia. 4th ed. K.F. Swaiman, S. Ashwal, D.M. Ferrero (Eds.).
2. Lee Y.H., Choi K.V., Moon J.H., Jun H.J., Kang H.R., Oh S.I., et al. Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy. J Transl Med 2012, 10:58.
3. Ukai R., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 2007, 24:508-520.
4. Pulsipher M.A., Levine J.E., Hayashi R.J., Chan K.W., Anderson P., Duerst R., et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant 2005, 35:361-367.
5. Rhodes B., Anderlini P. Allogeneicperipheral blood stem cell collection as of 2008. Transfus Apher Sci 2008, 38:219-227.
6. Styczynski J., Balduzzi A., Gil L., Labopin M., Hamladji R.M., Marktel S., et al. European group for blood and marrow transplantation pediatric diseases working party. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European group for blood and marrow transplantation pediatric diseases working party study. Blood 2012, 119:2935-2942.
7. Veljkovic D., Vujic D., Nonkovic O.S., Jevtic D., Zecevic Z., Lazic E. Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors. Ther Apher Dial 2011, 15:579-586.
8. Duning T., Schiffbauer H., Warnecke T., Mohammadi S., Floel A., Kolpatzik K., et al. G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS ONE 2011, 6:e17770.
9. England T.J., Abaei M., Auer D.P., Lowe J., Jones D.R., Sare G., et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 2012, 43:405-411.
10. Pezzoli G., Tesei S., Canesi M., Sacilotto G., Vittorio M., Mizuno Y., et al. The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. Clin Neurol Neurosurg 2010, 112:65-67.
11. Schneider A., Kuhn H.G., Schäbitz W.R. A role for G-CSF (granulocyte colony stimulating factor) in the central nervous system. Cell Cycle 2005, 4:1753-1757.
12. Shin J.W., Lee J.K., Lee J.E., Min W.K., Schuchman E.H., Jin H.K., et al. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model. Stem Cells 2011, 29:1075-1089.
13. Titomanlio L., Kavelaars A., Dalous J., Mani S., El Ghouzzi V., Heijnen C., et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 2011, 70:698-712.
14. Aharonowiz M., Einstein O., Fainstein N., Lassmann H., Reubinoff B., Ben-Hur T. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS ONE 2008, 3:e3145.
15. Ben-Hur T. Immunomodulation by neural stem cells. J Neurol Sci 2008, 265:102-104.
16. Einstein O., Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 2008, 65:452-456.
17. Locatelli F., Bersano A., Ballabio E., Lanfranconi S., Papadimitriou D., Strazzer S., et al. Stem cell therapy in stroke. Cell Mol Life Sci 2009, 66:757-772.
18. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.
19. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003, 100:8407-8411.
20. Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005, 66:543-551.
21. Mathieu M., Bartunek J., El Oumeiri B., Touihri K., Hadad I., Thoma P., et al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg 2009, 138:646-653.
22. Reich D.M., Hau S., Stahl T., Scholz M., Naumann W., Emmrich F., et al. Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells. BMC Neurosci 2008, 9:91.
23. Nicola N.A., Begley C.G., Metcalf D. Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells. Nature 1985, 314:625-628.
24. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005, 115:2083-2098.
25. Schäbitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003, 34:745-751.
26. Six I., Gasan G., Mura E., Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 2003, 458:327-328.
27. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S., et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
28. Gibson C.L., Bath P.M., Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005, 25:431-439.
29. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., et al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 2006, 26:402-413.
30. De Freria C.M., Barbizan R., De Oliveira A.L. Granulocyte colony stimulating factor neuroprotective effects on spinal motoneurons after ventral root avulsion. Synapse 2012, 66:128-141.
31. Leibundgut K., Müller C., Müller K., Ridolfi-Lüthy A., Hirt A. Tunneled, double lumen Broviac catheters are useful, efficient and safe in children undergoing peripheral blood progenitor cell harvesting and transplantation. Bone Marrow Transplant 1996, 17:663-667.
32. Haut P.R., Cohn S., Morgan E., Hubbell M., Danner-Koptik K., Olszewski M., et al. Efficacy of autologous peripheral blood stem cell (PBSC) harvest and engraftment after ablative chemotherapy in pediatric patients. Biol Blood Marrow Transplant 1998, 4:38-42.
33. Shen V., Woodbury C., Killen R., Van de Ven C., Sender L., Cairo M.S. Collection and use of peripheral blood stem cells in young children with refractory solid tumors. Bone Marrow Transplant 1997, 19:197-204.
34. Takaue Y., Watanabe T., Abe T., Okamoto Y., Saito S., Shimizu T., et al. Experience with peripheral blood stem cell collection for autografts in children with active cancer. Bone Marrow Transplant 1992, 10:241-248.
35. Díaz M.A., Sevilla J., de la Rubia J., Verdeguer A., Espigado I., Vicent M.G., et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica 2003, 88:919-922.
36. Hofling A.A., Sands M.S., Lublin D.M., Bauer G., Devine S. Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation. J Clin Apher 2004, 19:151-153.